Great Point Partners’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Great Point Partners’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-86,302	Closed	-$3.76M	–	52
2023 Q3	$3.76M	Buy	+86,302	New	+$3.08M	0.71%	37
2023 Q1	–	Sell	-133,000	Closed	-$6.03M	–	56
2022 Q4	$6.03M	Buy	+133,000	New	+$8.61M	1.25%	31
2021 Q3	–	Sell	-100,000	Closed	-$16.2M	–	46
2021 Q2	$16.2M	Sell	100,000 -35,000	-26%	-$5.62M	3.61%	10
2021 Q1	$23.1M	Buy	+135,000	New	+$26.7M	4.78%	10
2019 Q4	–	Sell	-300,000	Closed	-$23.4M	–	52
2019 Q3	$23.4M	Hold	300,000	–	–	2.47%	15
2019 Q2	$30.9M	Buy	+300,000	New	+$23.4M	3.75%	10
2017 Q1	–	Sell	-870,261	Closed	-$4.13M	–	47
2016 Q4	$4.13M	Buy	870,261 +642,604	+282%	+$3.5M	0.91%	25
2016 Q3	$1.5M	Buy	+227,657	New	+$1.21M	0.39%	28

Other funds holding MRTX

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return

Braslyn New Providence, Bahamas $7.81M AUM 338.68% 1-Year Est. Return